{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:46:22Z","timestamp":1782441982396,"version":"3.54.5"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The clinical use of the anticancer drug doxorubicin (Dox) is limited by irreversible cardiotoxicity. The pathophysiological relevance of different cardiac cell types, including endothelial progenitor cells (EPC), in this process is unclear. Since progenitor cells are particularly relevant for tissue regeneration, we hypothesize that residual damage resulting from Dox-based therapeutic regimen may influence their endothelial differentiation accuracy. Therefore, we comparatively investigated the response of murine embryonic stem cells (mESC), endothelial progenitor cells (EC d4) and terminally differentiated endothelial-like cells (EC d6) following exposure to Dox and selected pharmacological inhibitors of DNA repair\/DNA damage response (DDR) (RAD51i B02; HDACi entinostat (EST)). We show that EC d4 exhibit enhanced Dox sensitivity as compared to mESC and EC d6. EdU incorporation and replication fork progression analyses revealed pronounced agent-specific differences between mESC, EC d4 and EC d6. Furthermore, DNA damage formation varied in a drug-dependent manner, with mESC showing enhanced residual levels of DNA single-strand breaks (SSB) as compared to EC d4 and EC d6 while EC d6 revealed highest levels of DNA double-strand breaks (DSB). Dox treatment of EC d4 did not prevent their further differentiation into EC d6. However, it caused several functional impairments in the surviving EC d6 progeny, including defects in mitochondrial homeostasis, endothelial barrier function related to cell-cell adhesion factors (ZO1, VE-cadherin), cytokine response and low-density lipoprotein (LDL) uptake. This is accompanied by increased senescence. Summarizing, we demonstrate both overlapping and agent-specific responses of mESC, EC d4 and EC d6 to Dox and DNA repair\/DDR inhibitors. Notably, drug treatment of EPC (EC d4) causes multiple dysfunctions in differentiated EC d6. Hence, pharmacological measures aiming to specifically protect EPC from Dox-induced damage are suggested to foster the maintenance of healthy endothelial functionality during regeneration, thereby lowering the risk of detrimental late cardiotoxicity resulting from Dox-based anticancer regimen.<\/jats:p>","DOI":"10.1186\/s13287-026-05087-1","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:47:03Z","timestamp":1782388023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Endothelial progenitor cell susceptibility to DNA damaging and DDR-modulating compounds determines endothelial differentiation accuracy"],"prefix":"10.1186","volume":"17","author":[{"given":"Sina","family":"Federmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Westerhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas S.","family":"Reichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"5087_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/1471-2407-10-337","volume":"10","author":"LA Smith","year":"2010","unstructured":"Smith LA, Cornelius VR, Plummer CJ, Levitt G, Verrill M, Canney P, Jones A. Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer. 2010;10:337.","journal-title":"BMC Cancer"},{"key":"5087_CR2","doi-asserted-by":"crossref","unstructured":"Marinello J, Delcuratolo M, Capranico G. Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives. Int J Mol Sci, 19 (2018).","DOI":"10.3390\/ijms19113480"},{"key":"5087_CR3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.molcel.2007.11.015","volume":"28","author":"JW Harper","year":"2007","unstructured":"Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell. 2007;28:739\u201345.","journal-title":"Mol Cell"},{"key":"5087_CR4","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.1111\/febs.15583","volume":"288","author":"SY van der Zanden","year":"2021","unstructured":"van der Zanden SY, Qiao X, Neefjes J. New insights into the activities and toxicities of the old anticancer drug doxorubicin. FEBS J. 2021;288:6095\u2013111.","journal-title":"FEBS J"},{"key":"5087_CR5","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","volume":"126","author":"KB Wallace","year":"2020","unstructured":"Wallace KB, Sardao VA, Oliveira PJ. Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy. Circ Res. 2020;126:926\u201341.","journal-title":"Circ Res"},{"key":"5087_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","volume":"57","author":"DA Gewirtz","year":"1999","unstructured":"Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol. 1999;57:727\u201341.","journal-title":"Biochem Pharmacol"},{"key":"5087_CR7","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.15252\/embr.201439245","volume":"15","author":"BG Childs","year":"2014","unstructured":"Childs BG, Baker DJ, Kirkland JL, Campisi J, van Deursen JM. Senescence and apoptosis: dueling or complementary cell fates? EMBO Rep. 2014;15:1139\u201353.","journal-title":"EMBO Rep"},{"key":"5087_CR8","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1161\/01.CIR.0000146889.46519.27","volume":"110","author":"N Nozaki","year":"2004","unstructured":"Nozaki N, Shishido T, Takeishi Y, Kubota I. Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice. Circulation. 2004;110:2869\u201374.","journal-title":"Circulation"},{"key":"5087_CR9","doi-asserted-by":"publisher","first-page":"e2564","DOI":"10.1038\/cddis.2016.418","volume":"8","author":"C Henninger","year":"2017","unstructured":"Henninger C, Fritz G. Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers. Cell Death Dis. 2017;8:e2564.","journal-title":"Cell Death Dis"},{"key":"5087_CR10","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1002\/ctm2.124","volume":"10","author":"C Hu","year":"2020","unstructured":"Hu C, Zhang X, Zhang N, Wei WY, Li LL, Ma ZG, Tang QZ. Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin-induced cardiotoxicity. Clin Transl Med. 2020;10:e124.","journal-title":"Clin Transl Med"},{"key":"5087_CR11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41418-019-0372-z","volume":"27","author":"X Zhang","year":"2020","unstructured":"Zhang X, Hu C, Kong CY, Song P, Wu HM, Xu SC, Yuan YP, Deng W, Ma ZG, Tang QZ. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ. 2020;27:540\u201355.","journal-title":"Cell Death Differ"},{"key":"5087_CR12","doi-asserted-by":"publisher","first-page":"101747","DOI":"10.1016\/j.redox.2020.101747","volume":"37","author":"C Hu","year":"2020","unstructured":"Hu C, Zhang X, Song P, Yuan YP, Kong CY, Wu HM, Xu SC, Ma ZG, Tang QZ. Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP\/PKA\/SIRT1 pathway. Redox Biol. 2020;37:101747.","journal-title":"Redox Biol"},{"key":"5087_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cbi.2008.09.012","volume":"177","author":"F Bernuzzi","year":"2009","unstructured":"Bernuzzi F, Recalcati S, Alberghini A, Cairo G. Reactive oxygen species-independent apoptosis in doxorubicin-treated H9c2 cardiomyocytes: role for heme oxygenase-1 down-modulation. Chem Biol Interact. 2009;177:12\u201320.","journal-title":"Chem Biol Interact"},{"key":"5087_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11010-016-2653-x","volume":"413","author":"T Rharass","year":"2016","unstructured":"Rharass T, Gbankoto A, Canal C, Kursunluoglu G, Bijoux A, Panakova D, Ribou AC. Oxidative stress does not play a primary role in the toxicity induced with clinical doses of doxorubicin in myocardial H9c2 cells. Mol Cell Biochem. 2016;413:199\u2013215.","journal-title":"Mol Cell Biochem"},{"key":"5087_CR15","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.freeradbiomed.2003.08.005","volume":"35","author":"BB Hasinoff","year":"2003","unstructured":"Hasinoff BB, Patel D, Wu X. The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicin. Free Radic Biol Med. 2003;35:1469\u201379.","journal-title":"Free Radic Biol Med"},{"key":"5087_CR16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s12012-019-09554-5","volume":"20","author":"BB Hasinoff","year":"2020","unstructured":"Hasinoff BB, Patel D, Wu X. The Role of Topoisomerase IIbeta in the Mechanisms of Action of the Doxorubicin Cardioprotective Agent Dexrazoxane. Cardiovasc Toxicol. 2020;20:312\u201320.","journal-title":"Cardiovasc Toxicol"},{"key":"5087_CR17","doi-asserted-by":"publisher","first-page":"8839","DOI":"10.1158\/0008-5472.CAN-07-1649","volume":"67","author":"YL Lyu","year":"2007","unstructured":"Lyu YL, Kerrigan JE, Lin CP, Azarova AM, Tsai YC, Ban Y, Liu LF. Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Res. 2007;67:8839\u201346.","journal-title":"Cancer Res"},{"key":"5087_CR18","doi-asserted-by":"publisher","first-page":"e008209","DOI":"10.1161\/CIRCHEARTFAILURE.120.008209","volume":"14","author":"E Jirkovsky","year":"2021","unstructured":"Jirkovsky E, Jirkovska A, Bavlovic-Piskackova H, Skalicka V, Pokorna Z, Karabanovich G, Kollarova-Brazdova P, Kubes J, Lencova-Popelova O, Mazurova Y, Adamcova M, Lyon AR, Roh J, Simunek T, Sterbova-Kovarikova P, Sterba M. Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation. Circ Heart Fail. 2021;14:e008209.","journal-title":"Circ Heart Fail"},{"key":"5087_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.phrs.2017.03.016","volume":"127","author":"D Cappetta","year":"2018","unstructured":"Cappetta D, Rossi F, Piegari E, Quaini F, Berrino L, Urbanek K, De Angelis A. Doxorubicin targets multiple players: A new view of an old problem. Pharmacol Res. 2018;127:4\u201314.","journal-title":"Pharmacol Res"},{"key":"5087_CR20","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1161\/CIRCULATIONAHA.109.895771","volume":"121","author":"A De Angelis","year":"2010","unstructured":"De Angelis A, Piegari E, Cappetta D, Marino L, Filippelli A, Berrino L, Ferreira-Martins J, Zheng H, Hosoda T, Rota M, Urbanek K, Kajstura J, Leri A, Rossi F, Anversa P. Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation. 2010;121:276\u201392.","journal-title":"Circulation"},{"key":"5087_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","volume":"12","author":"E Christidi","year":"2021","unstructured":"Christidi E, Brunham LR. Regulated cell death pathways in doxorubicin-induced cardiotoxicity. Cell Death Dis. 2021;12:339.","journal-title":"Cell Death Dis"},{"key":"5087_CR22","doi-asserted-by":"crossref","unstructured":"Kucuk P, Abbey L, Schmitt J, Henninger C, Fritz G. Cardiomyocytes, cardiac endothelial cells and fibroblasts contribute to anthracycline-induced cardiac injury through RAS-homologous small GTPases RAC1 and CDC42. Pharmacol Res, (2024) 107165.","DOI":"10.1016\/j.phrs.2024.107165"},{"key":"5087_CR23","doi-asserted-by":"publisher","first-page":"13144","DOI":"10.1073\/pnas.1616168113","volume":"113","author":"M Rasanen","year":"2016","unstructured":"Rasanen M, Degerman J, Nissinen TA, Miinalainen I, Kerkela R, Siltanen A, Backman JT, Mervaala E, Hulmi JJ, Kivela R, Alitalo K. VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection. Proc Natl Acad Sci U S A. 2016;113:13144\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5087_CR24","doi-asserted-by":"crossref","unstructured":"Grakova EV, Shilov SN, Kopeva KV, Berezikova EN, Popova AA, Neupokoeva MN, Ratushnyak ET, Teplyakov AT. Anthracycline-Induced Cardiotoxicity: The Role of Endothelial Dysfunction, Cardiology, 146 (2021) 315\u201323.","DOI":"10.1159\/000512771"},{"key":"5087_CR25","first-page":"15","volume":"7","author":"RK Hoffman","year":"2021","unstructured":"Hoffman RK, Kim BJ, Shah PD, Carver J, Ky B, Ryeom S. Damage to cardiac vasculature may be associated with breast cancer treatment-induced cardiotoxicity. Cardiooncology. 2021;7:15.","journal-title":"Cardiooncology"},{"key":"5087_CR26","doi-asserted-by":"publisher","first-page":"166352","DOI":"10.1016\/j.bbadis.2022.166352","volume":"1868","author":"IY Abdelgawad","year":"2022","unstructured":"Abdelgawad IY, Agostinucci K, Zordoky BN. Cardiovascular ramifications of therapy-induced endothelial cell senescence in cancer survivors. Biochim Biophys Acta Mol Basis Dis. 2022;1868:166352.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5087_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00395-013-0334-4","volume":"108","author":"E Piegari","year":"2013","unstructured":"Piegari E, De Angelis A, Cappetta D, Russo R, Esposito G, Costantino S, Graiani G, Frati C, Prezioso L, Berrino L, Urbanek K, Quaini F, Rossi F. Doxorubicin induces senescence and impairs function of human cardiac progenitor cells. Basic Res Cardiol. 2013;108:334.","journal-title":"Basic Res Cardiol"},{"key":"5087_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijcard.2015.03.438","volume":"189","author":"A De Angelis","year":"2015","unstructured":"De Angelis A, Piegari E, Cappetta D, Russo R, Esposito G, Ciuffreda LP, Ferraiolo FA, Frati C, Fagnoni F, Berrino L, Quaini F, Rossi F, Urbanek K. SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells. Int J Cardiol. 2015;189:30\u201344.","journal-title":"Int J Cardiol"},{"key":"5087_CR29","doi-asserted-by":"publisher","first-page":"e0144513","DOI":"10.1371\/journal.pone.0144513","volume":"10","author":"L Kan","year":"2015","unstructured":"Kan L, Smith A, Chen M, Ledford BT, Fan H, Liu Z, He JQ. Rho-Associated Kinase Inhibitor (Y-27632) Attenuates Doxorubicin-Induced Apoptosis of Human Cardiac Stem Cells. PLoS ONE. 2015;10:e0144513.","journal-title":"PLoS ONE"},{"key":"5087_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.bcp.2019.03.038","volume":"164","author":"C Henninger","year":"2019","unstructured":"Henninger C, Pohlmann S, Ziegler V, Ohlig J, Schmitt J, Fritz G. Distinct contribution of Rac1 expression in cardiomyocytes to anthracycline-induced cardiac injury. Biochem Pharmacol. 2019;164:82\u201393.","journal-title":"Biochem Pharmacol"},{"key":"5087_CR31","doi-asserted-by":"publisher","first-page":"e22977","DOI":"10.1096\/fj.202201885RR","volume":"37","author":"J Chen","year":"2023","unstructured":"Chen J, Chapski DJ, Jong J, Awada J, Wang Y, Slamon DJ, Vondriska TM, Packard RRS. Integrative transcriptomics and cell systems analyses reveal protective pathways controlled by Igfbp-3 in anthracycline-induced cardiotoxicity. FASEB J. 2023;37:e22977.","journal-title":"FASEB J"},{"key":"5087_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1124\/jpet.119.264580","volume":"373","author":"P Kollarova-Brazdova","year":"2020","unstructured":"Kollarova-Brazdova P, Jirkovska A, Karabanovich G, Pokorna Z, Bavlovic Piskackova H, Jirkovsky E, Kubes J, Lencova-Popelova O, Mazurova Y, Adamcova M, Skalicka V, Sterbova-Kovarikova P, Roh J, Simunek T, Sterba M. Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase IIbeta Interaction as a Prerequisite for Effective Protection against Anthracycline Cardiotoxicity. J Pharmacol Exp Ther. 2020;373:402\u201315.","journal-title":"J Pharmacol Exp Ther"},{"key":"5087_CR33","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","volume":"18","author":"S Zhang","year":"2012","unstructured":"Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu YL, Liu LF, Yeh ET. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med. 2012;18:1639\u201342.","journal-title":"Nat Med"},{"key":"5087_CR34","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1242\/dev.110.4.1341","volume":"110","author":"J Nichols","year":"1990","unstructured":"Nichols J, Evans EP, Smith AG. Establishment of germ-line-competent embryonic stem (ES) cells using differentiation inhibiting activity. Development. 1990;110:1341\u20138.","journal-title":"Development"},{"key":"5087_CR35","first-page":"118711","volume":"1867","author":"SK Jahn","year":"2020","unstructured":"Jahn SK, Hennicke T, Kassack MU, Drews L, Reichert AS, Fritz G. Distinct influence of the anthracycline derivative doxorubicin on the differentiation efficacy of mESC-derived endothelial progenitor cells. Bba-Mol Cell Res. 2020;1867:118711.","journal-title":"Bba-Mol Cell Res"},{"key":"5087_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/toxsci\/kfu264","volume":"144","author":"T Hennicke","year":"2015","unstructured":"Hennicke T, Nieweg K, Brockmann N, Kassack MU, Gottmann K, Fritz G. mESC-based in vitro differentiation models to study vascular response and functionality following genotoxic insults. Toxicol Sci. 2015;144:138\u201350.","journal-title":"Toxicol Sci"},{"key":"5087_CR37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0091-679X(04)75014-1","volume":"75","author":"PL Olive","year":"2004","unstructured":"Olive PL. Detection of DNA damage in individual cells by analysis of histone H2AX phosphorylation. Methods Cell Biol. 2004;75:355\u201373.","journal-title":"Methods Cell Biol"},{"key":"5087_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.tcb.2013.09.003","volume":"24","author":"M Zimmermann","year":"2014","unstructured":"Zimmermann M, de Lange T. 53BP1: pro choice in DNA repair. Trends Cell Biol. 2014;24:108\u201317.","journal-title":"Trends Cell Biol"},{"key":"5087_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nprot.2006.5","volume":"1","author":"PL Olive","year":"2006","unstructured":"Olive PL, Banath JP. The comet assay: a method to measure DNA damage in individual cells. Nat Protoc. 2006;1:23\u20139.","journal-title":"Nat Protoc"},{"key":"5087_CR40","doi-asserted-by":"publisher","first-page":"E4311","DOI":"10.1073\/pnas.1605828113","volume":"113","author":"S Hampp","year":"2016","unstructured":"Hampp S, Kiessling T, Buechle K, Mansilla SF, Thomale J, Rall M, Ahn J, Pospiech H, Gottifredi V, Wiesmuller L. DNA damage tolerance pathway involving DNA polymerase iota and the tumor suppressor p53 regulates DNA replication fork progression. Proc Natl Acad Sci U S A. 2016;113:E4311\u20134319.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5087_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-0716-1217-0_4","volume":"2267","author":"S Biber","year":"2021","unstructured":"Biber S, Wiesmuller L. Analysis of Replication Dynamics Using the Single-Molecule DNA Fiber Spreading Assay. Methods Mol Biol. 2021;2267:57\u201371.","journal-title":"Methods Mol Biol"},{"key":"5087_CR42","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1021\/jm201173g","volume":"55","author":"F Huang","year":"2012","unstructured":"Huang F, Mazina OM, Zentner IJ, Cocklin S, Mazin AV. Inhibition of Homologous Recombination in Human Cells by Targeting RAD51 Recombinase. J Med Chem. 2012;55:3011\u201320.","journal-title":"J Med Chem"},{"key":"5087_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcdb.2020.08.010","volume":"113","author":"IE Wassing","year":"2021","unstructured":"Wassing IE, Esashi F, RAD51. Beyond the break. Semin Cell Dev Biol. 2021;113:38\u201346.","journal-title":"Semin Cell Dev Biol"},{"key":"5087_CR44","doi-asserted-by":"crossref","unstructured":"Goder A, Emmerich C, Nikolova T, Kiweler N, Schreiber M, Kuhl T, Imhof D, Christmann M, Heinzel T, Schneider G, Kramer OH. HDAC1 and HDAC2 integrate checkpoint kinase phosphorylation and cell fate through the phosphatase-2A subunit PR130. Nat Commun, 9 (2018).","DOI":"10.1038\/s41467-018-03096-0"},{"key":"5087_CR45","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00432-019-03118-4","volume":"146","author":"N Kiweler","year":"2020","unstructured":"Kiweler N, Wunsch D, Wirth M, Mahendrarajah N, Schneider G, Stauber RH, Brenner W, Butter F, Kramer OH. Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes. J Cancer Res Clin Oncol. 2020;146:343\u201356.","journal-title":"J Cancer Res Clin Oncol"},{"key":"5087_CR46","doi-asserted-by":"publisher","first-page":"49053","DOI":"10.1074\/jbc.M105192200","volume":"276","author":"GD Luker","year":"2001","unstructured":"Luker GD, Flagg TP, Sha Q, Luker KE, Pica CM, Nichols CG, Piwnica-Worms D. MDR1 P-glycoprotein reduces influx of substrates without affecting membrane potential. J Biol Chem. 2001;276:49053\u201360.","journal-title":"J Biol Chem"},{"key":"5087_CR47","doi-asserted-by":"publisher","first-page":"662","DOI":"10.4161\/cc.9.4.10764","volume":"9","author":"M Lobrich","year":"2010","unstructured":"Lobrich M, Shibata A, Beucher A, Fisher A, Ensminger M, Goodarzi AA, Barton O, Jeggo PA. gammaH2AX foci analysis for monitoring DNA double-strand break repair: strengths, limitations and optimization. Cell Cycle. 2010;9:662\u20139.","journal-title":"Cell Cycle"},{"key":"5087_CR48","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1093\/nar\/gkn550","volume":"36","author":"A Kinner","year":"2008","unstructured":"Kinner A, Wu W, Staudt C, Iliakis G. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res. 2008;36:5678\u201394.","journal-title":"Nucleic Acids Res"},{"key":"5087_CR49","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nrc2523","volume":"8","author":"WM Bonner","year":"2008","unstructured":"Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, Pommier Y. GammaH2AX and cancer. Nat Rev Cancer. 2008;8:957\u201367.","journal-title":"Nat Rev Cancer"},{"key":"5087_CR50","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2010.03.012","volume":"141","author":"SF Bunting","year":"2010","unstructured":"Bunting SF, Callen E, Wong N, Chen HT, Polato F, Gunn A, Bothmer A, Feldhahn N, Fernandez-Capetillo O, Cao L, Xu X, Deng CX, Finkel T, Nussenzweig M, Stark JM, Nussenzweig A. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell. 2010;141:243\u201354.","journal-title":"Cell"},{"key":"5087_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0300-483X(03)00287-7","volume":"193","author":"M Christmann","year":"2003","unstructured":"Christmann M, Tomicic MT, Roos WP, Kaina B. Mechanisms of human DNA repair: an update. Toxicology. 2003;193:3\u201334.","journal-title":"Toxicology"},{"key":"5087_CR52","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1038\/s41467-020-17324-z","volume":"11","author":"M Berti","year":"2020","unstructured":"Berti M, Teloni F, Mijic S, Ursich S, Fuchs J, Palumbieri MD, Krietsch J, Schmid JA, Garcin EB, Gon S, Modesti M, Altmeyer M, Lopes M. Sequential role of RAD51 paralog complexes in replication fork remodeling and restart. Nat Commun. 2020;11:3531.","journal-title":"Nat Commun"},{"key":"5087_CR53","first-page":"10017","volume":"44","author":"WP Roos","year":"2016","unstructured":"Roos WP, Krumm A. The multifaceted influence of histone deacetylases on DNA damage signalling and DNA repair. Nucleic Acids Res. 2016;44:10017\u201330.","journal-title":"Nucleic Acids Res"},{"key":"5087_CR54","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.dnarep.2007.02.015","volume":"6","author":"RD Paulsen","year":"2007","unstructured":"Paulsen RD, Cimprich KA. The ATR pathway: fine-tuning the fork. DNA Repair (Amst). 2007;6:953\u201366.","journal-title":"DNA Repair (Amst)"},{"key":"5087_CR55","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1158\/1535-7163.MCT-12-1242","volume":"12","author":"KT Thurn","year":"2013","unstructured":"Thurn KT, Thomas S, Raha P, Qureshi I, Munster PN. Histone deacetylase regulation of ATM-mediated DNA damage signaling. Mol Cancer Ther. 2013;12:2078\u201387.","journal-title":"Mol Cancer Ther"},{"key":"5087_CR56","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.18632\/oncotarget.14062","volume":"8","author":"J Zhao","year":"2017","unstructured":"Zhao J, Xie C, Edwards H, Wang G, Taub JW, Ge Y. Histone deacetylases 1 and 2 cooperate in regulating BRCA1, CHK1, and RAD51 expression in acute myeloid leukemia cells. Oncotarget. 2017;8:6319\u201329.","journal-title":"Oncotarget"},{"key":"5087_CR57","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1158\/1535-7163.MCT-15-0374","volume":"14","author":"AP Wiegmans","year":"2015","unstructured":"Wiegmans AP, Yap PY, Ward A, Lim YC, Khanna KK. Differences in Expression of Key DNA Damage Repair Genes after Epigenetic-Induced BRCAness Dictate Synthetic Lethality with PARP1 Inhibition. Mol Cancer Ther. 2015;14:2321\u201331.","journal-title":"Mol Cancer Ther"},{"key":"5087_CR58","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/978-94-007-2869-1_18","volume":"942","author":"A Mordente","year":"2012","unstructured":"Mordente A, Meucci E, Silvestrini A, Martorana GE, Giardina B. Anthracyclines and mitochondria. Adv Exp Med Biol. 2012;942:385\u2013419.","journal-title":"Adv Exp Med Biol"},{"key":"5087_CR59","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2174\/187152508785909474","volume":"6","author":"AL Ferreira","year":"2008","unstructured":"Ferreira AL, Matsubara LS, Matsubara BB. Anthracycline-induced cardiotoxicity. Cardiovasc Hematol Agents Med Chem. 2008;6:278\u201381.","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"5087_CR60","doi-asserted-by":"publisher","first-page":"123945","DOI":"10.1016\/j.lfs.2025.123945","volume":"380","author":"P Bhadra","year":"2025","unstructured":"Bhadra P, Yadav P, Kaur S, Hanumantharayudu PT, Arunachalam S. The role of ferroptosis in doxorubicin-induced cardiotoxicity - An update. Life Sci. 2025;380:123945.","journal-title":"Life Sci"},{"key":"5087_CR61","doi-asserted-by":"crossref","unstructured":"Mann J, Niedermayer K, Krautstrunk J, Abbey L, Wiesmuller L, Piekorz RP, Fritz G. Combined inhibition of RAD51 and CHK1 causes synergistic toxicity in cisplatin resistant cancer cells by triggering replication fork collapse. Int J Cancer, (2024).","DOI":"10.1002\/ijc.35164"},{"key":"5087_CR62","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.yjmcc.2018.10.007","volume":"124","author":"R Song","year":"2018","unstructured":"Song R, Yang Y, Lei H, Wang G, Huang Y, Xue W, Wang Y, Yao L, Zhu Y. HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving alpha-tubulin acetylation. J Mol Cell Cardiol. 2018;124:58\u201369.","journal-title":"J Mol Cell Cardiol"},{"key":"5087_CR63","doi-asserted-by":"publisher","first-page":"603","DOI":"10.7150\/thno.67410","volume":"12","author":"BR McAlpin","year":"2022","unstructured":"McAlpin BR, Mahalingam R, Singh AK, Dharmaraj S, Chrisikos TT, Boukelmoune N, Kavelaars A, Heijnen CJ. HDAC6 inhibition reverses long-term doxorubicin-induced cognitive dysfunction by restoring microglia homeostasis and synaptic integrity. Theranostics. 2022;12:603\u201319.","journal-title":"Theranostics"},{"key":"5087_CR64","doi-asserted-by":"crossref","unstructured":"Sjakste N, Riekstina U. DNA damage and repair in differentiation of stem cells and cells of connective cell lineages: A trigger or a complication? Eur J Histochem, 65 (2021).","DOI":"10.4081\/ejh.2021.3236"},{"key":"5087_CR65","doi-asserted-by":"publisher","first-page":"203882","DOI":"10.1016\/j.cdev.2023.203882","volume":"177","author":"TC Karagiannis","year":"2024","unstructured":"Karagiannis TC, Orlowski C, Ververis K, Pitsillou E, Sarila G, Keating ST, Foong LJ, Fabris S, Ngo-Nguyen C, Malik N, Okabe J, Hung A, Mantamadiotis T, El-Osta A. gammaH2AX in mouse embryonic stem cells: Distribution during differentiation and following gamma-irradiation. Cells Dev. 2024;177:203882.","journal-title":"Cells Dev"},{"key":"5087_CR66","doi-asserted-by":"publisher","first-page":"21105","DOI":"10.1073\/pnas.1111919109","volume":"108","author":"M Bauer","year":"2011","unstructured":"Bauer M, Goldstein M, Christmann M, Becker H, Heylmann D, Kaina B. Human monocytes are severely impaired in base and DNA double-strand break repair that renders them vulnerable to oxidative stress. Proc Natl Acad Sci U S A. 2011;108:21105\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5087_CR67","doi-asserted-by":"publisher","first-page":"17010","DOI":"10.1073\/pnas.0701743104","volume":"104","author":"L Narciso","year":"2007","unstructured":"Narciso L, Fortini P, Pajalunga D, Franchitto A, Liu P, Degan P, Frechet M, Demple B, Crescenzi M, Dogliotti E. Terminally differentiated muscle cells are defective in base excision DNA repair and hypersensitive to oxygen injury. Proc Natl Acad Sci U S A. 2007;104:17010\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5087_CR68","doi-asserted-by":"publisher","first-page":"16384","DOI":"10.1038\/s41598-023-43737-z","volume":"13","author":"M Kim","year":"2023","unstructured":"Kim M, Jang HJ, Baek SY, Choi KJ, Han DH, Sung JS. Regulation of base excision repair during adipogenesis and osteogenesis of bone marrow-derived mesenchymal stem cells. Sci Rep. 2023;13:16384.","journal-title":"Sci Rep"},{"key":"5087_CR69","doi-asserted-by":"publisher","first-page":"10660","DOI":"10.1038\/ncomms10660","volume":"7","author":"AK Ahuja","year":"2016","unstructured":"Ahuja AK, Jodkowska K, Teloni F, Bizard AH, Zellweger R, Herrador R, Ortega S, Hickson ID, Altmeyer M, Mendez J, Lopes M. A short G1 phase imposes constitutive replication stress and fork remodelling in mouse embryonic stem cells. Nat Commun. 2016;7:10660.","journal-title":"Nat Commun"},{"key":"5087_CR70","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1042\/BST20200454","volume":"49","author":"CA Austin","year":"2021","unstructured":"Austin CA, Cowell IG, Khazeem MM, Lok D, Ng HT. TOP2B\u2019s contributions to transcription. Biochem Soc Trans. 2021;49:2483\u201393.","journal-title":"Biochem Soc Trans"},{"key":"5087_CR71","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1046\/j.1432-1033.2003.03814.x","volume":"270","author":"RL Low","year":"2003","unstructured":"Low RL, Orton S, Friedman DB. A truncated form of DNA topoisomerase IIbeta associates with the mtDNA genome in mammalian mitochondria. Eur J Biochem. 2003;270:4173\u201386.","journal-title":"Eur J Biochem"},{"key":"5087_CR72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1432-0436.2006.00052.x","volume":"74","author":"FD Houghton","year":"2006","unstructured":"Houghton FD. Energy metabolism of the inner cell mass and trophectoderm of the mouse blastocyst. Differentiation. 2006;74:11\u20138.","journal-title":"Differentiation"},{"key":"5087_CR73","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s00018-015-1834-1","volume":"72","author":"A Prigione","year":"2015","unstructured":"Prigione A, Ruiz-Perez MV, Bukowiecki R, Adjaye J. Metabolic restructuring and cell fate conversion. Cell Mol Life Sci. 2015;72:1759\u201377.","journal-title":"Cell Mol Life Sci"},{"key":"5087_CR74","doi-asserted-by":"crossref","unstructured":"Mboni-Johnston IM, Kouidrat NMZ, Hirsch C, Weber AG, Meissner A, Adjaye J, Schupp N. Sensitivity of Human Induced Pluripotent Stem Cells and Thereof Differentiated Kidney Proximal Tubular Cells towards Selected Nephrotoxins. Int J Mol Sci, 25 (2023).","DOI":"10.20944\/preprints202311.1480.v1"},{"key":"5087_CR75","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1038\/s41467-024-47008-x","volume":"15","author":"DMK van Soest","year":"2024","unstructured":"van Soest DMK, Polderman PE, den Toom WTF, Keijer JP, van Roosmalen MJ, Leyten TMF, Lehmann J, Zwakenberg S, De Henau S, van Boxtel R, Burgering BMT, Dansen TB. Mitochondrial H(2)O(2) release does not directly cause damage to chromosomal DNA. Nat Commun. 2024;15:2725.","journal-title":"Nat Commun"},{"key":"5087_CR76","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-genet-072920-022154","volume":"56","author":"JC Schimenti","year":"2022","unstructured":"Schimenti JC, Huang R, Li L, James R. Genome Maintenance in Mammalian Stem Cells. Annu Rev Genet. 2022;56:145\u201364.","journal-title":"Annu Rev Genet"},{"key":"5087_CR77","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1089\/scd.2010.0058","volume":"19","author":"ED Tichy","year":"2010","unstructured":"Tichy ED, Pillai R, Deng L, Liang L, Tischfield J, Schwemberger SJ, Babcock GF, Stambrook PJ. Mouse embryonic stem cells, but not somatic cells, predominantly use homologous recombination to repair double-strand DNA breaks. Stem Cells Dev. 2010;19:1699\u2013711.","journal-title":"Stem Cells Dev"},{"key":"5087_CR78","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.yexcr.2008.02.007","volume":"314","author":"ED Tichy","year":"2008","unstructured":"Tichy ED, Stambrook PJ. DNA repair in murine embryonic stem cells and differentiated cells. Exp Cell Res. 2008;314:1929\u201336.","journal-title":"Exp Cell Res"},{"key":"5087_CR79","doi-asserted-by":"publisher","first-page":"120018","DOI":"10.1016\/j.bbamcr.2025.120018","volume":"1872","author":"M Sekeres","year":"2025","unstructured":"Sekeres M, Lengle D, Abbey L, Kassack MU, Fischer F, Kurz T, Fritz G. Epigenetic targeting of DNA damage response (DDR)-related mechanisms to overcome acquired cisplatin resistance of tumor cells. Biochim Biophys Acta Mol Cell Res. 2025;1872:120018.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"5087_CR80","doi-asserted-by":"crossref","unstructured":"Jaiswal SK, Raj S, DePamphilis ML. Developmental Acquisition of p53 Functions. Genes (Basel), 12 (2021).","DOI":"10.20944\/preprints202110.0251.v1"},{"key":"5087_CR81","doi-asserted-by":"publisher","first-page":"10926","DOI":"10.1073\/pnas.0907601107","volume":"107","author":"Y Seki","year":"2010","unstructured":"Seki Y, Kurisaki A, Watanabe-Susaki K, Nakajima Y, Nakanishi M, Arai Y, Shiota K, Sugino H, Asashima M. TIF1beta regulates the pluripotency of embryonic stem cells in a phosphorylation-dependent manner. Proc Natl Acad Sci U S A. 2010;107:10926\u201331.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5087_CR82","doi-asserted-by":"crossref","unstructured":"Coppi L, Ligorio S, Mitro N, Caruso D, De Fabiani E, Crestani M. PGC1s and Beyond: Disentangling the Complex Regulation of Mitochondrial and Cellular Metabolism. Int J Mol Sci, 22 (2021).","DOI":"10.3390\/ijms22136913"},{"key":"5087_CR83","doi-asserted-by":"crossref","unstructured":"Xu J, Fei P, Simon DW, Morowitz MJ, Mehta PA, Du W. Crosstalk between DNA Damage Repair and Metabolic Regulation in Hematopoietic Stem Cells, Cells, 13 (2024).","DOI":"10.3390\/cells13090733"},{"key":"5087_CR84","doi-asserted-by":"crossref","unstructured":"Hellenthal KEM, Brabenec L, Wagner NM. Regulation and Dysregulation of Endothelial Permeability during Systemic Inflammation, Cells, 11 (2022).","DOI":"10.3390\/cells11121935"},{"key":"5087_CR85","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/cvr\/cvx226","volume":"114","author":"S Mundi","year":"2018","unstructured":"Mundi S, Massaro M, Scoditti E, Carluccio MA, van Hinsbergh VWM, Iruela-Arispe ML, De Caterina R. Endothelial permeability, LDL deposition, and cardiovascular risk factors-a review. Cardiovasc Res. 2018;114:35\u201352.","journal-title":"Cardiovasc Res"},{"key":"5087_CR86","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2174\/1568006054553435","volume":"5","author":"T Thum","year":"2005","unstructured":"Thum T, Bauersachs J. Endothelial progenitor cells as potential drug targets. Curr Drug Targets Cardiovasc Haematol Disord. 2005;5:277\u201386.","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"5087_CR87","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2174\/1389450119666180518111931","volume":"19","author":"J Feng","year":"2018","unstructured":"Feng J, Li Y, Nie Y. Non-Cardiomyocytes in Heart Regeneration. Curr Drug Targets. 2018;19:1077\u201386.","journal-title":"Curr Drug Targets"},{"key":"5087_CR88","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13287-015-0109-y","volume":"6","author":"F Ezquer","year":"2015","unstructured":"Ezquer F, Gutierrez J, Ezquer M, Caglevic C, Salgado HC, Calligaris SD. Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears. Stem Cell Res Ther. 2015;6:116.","journal-title":"Stem Cell Res Ther"},{"key":"5087_CR89","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13287-017-0472-y","volume":"8","author":"C Mao","year":"2017","unstructured":"Mao C, Hou X, Wang B, Chi J, Jiang Y, Zhang C, Li Z. Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats. Stem Cell Res Ther. 2017;8:18.","journal-title":"Stem Cell Res Ther"},{"key":"5087_CR90","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13287-018-0788-2","volume":"9","author":"D Silva Dos Santos","year":"2018","unstructured":"Silva Dos Santos D, Brasil GV, Ramos IPR, Mesquita FCP, Kasai-Brunswick TH, Christie MLA, Cahli GM, Barbosa RAQ, da Cunha ST, Pereira JX, Medei E, Campos de Carvalho AC, Carvalho AB, Goldenberg R. Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy. Stem Cell Res Ther. 2018;9:30.","journal-title":"Stem Cell Res Ther"},{"key":"5087_CR91","doi-asserted-by":"crossref","unstructured":"Lee EJ, Jang WB, Choi J, Lim HJ, Park S, Rethineswaran VK, Ha JS, Yun J, Hong YJ, Choi YJ, Kwon SM. The Protective Role of Glutathione against Doxorubicin-Induced Cardiotoxicity in Human Cardiac Progenitor Cells. Int J Mol Sci, 24 (2023).","DOI":"10.21203\/rs.3.rs-2519611\/v1"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05087-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05087-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05087-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:03:31Z","timestamp":1782439411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05087-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5087"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05087-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since the mouse ESC cells used in this study are an established cell line, ethics approval was not needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"226"}}